5//SEC Filing
Yalamanchi Naveen 5
Accession 0001140361-21-005123
CIK 0001281895other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 9:54 PM ET
Size
5.2 KB
Accession
0001140361-21-005123
Insider Transaction Report
Form 5
Yalamanchi Naveen
Director
Transactions
- Gift
Common Stock
2020-12-02−31,250→ 82,391 total(indirect: By Trust)
Footnotes (1)
- [F1]Excludes 17,530,044 shares beneficially owned by each of (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of the shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Special Purpose Fund II, LLC, which are investment funds managed by RTW, and (ii) Roderick Wong, M.D., who serves as the Managing Partner of Chief Investment Officer of RTW and who is a director of the Issuer and Chairman of the Issuer's Board of Directors, in which Dr. Yalamanchi has a pecuniary interest. Dr. Yalamanchi disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001725743
Filing Metadata
- Form type
- 5
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 9:54 PM ET
- Size
- 5.2 KB